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SumlTlary 
Interferon 3' (IFN-'y) exerts a variety of immunoregulatory  effects on several cell targets.  It is 
generally assumed that IFN-'y is specifically  produced by T  and large granular lymphocytes. In 
this study, we show that IFN-3' is constitutively expressed in resting mouse peritoneal macrophages 
(PM). Treatment of PM with cycloheximide results in a significant  accumulation of IFN-'y mRNA, 
suggesting that  a short-lived IFN-y mRNA accumulates when protein synthesis is inhibited. 
Moreover, treatment of PM with IFN-'y also results in a clear-cut accumulation of this mKNA. 
This effect is not observed in murine lymphocytes from mesenteric lymph nodes (which instead 
produce IFN-'y after phytohemagglutinin  treatment)  and in mouse cell lines.  The treatment of 
PM with IFN-'y also results in secretion of IFN-'y after 24-48 h. The upregulation  of IFN-'y 
expression is also found in PM from anti-asialo GMl-treated  nude mice. We suggest that  the 
ability of PM to produce this IFN-y is indicative of an autocrine mechanism.  The macrophage 
IFN-3' may play a role in  the regulation  of cell differentiation  and immune  response. 
I 
FN-'y  displays  potent  immunomodulatory  effects  on  a 
variety of immune cells in vitro and in vivo (1). In macro- 
phages, IFN-3' is involved in cell activation (2) as well as in 
the induction  of MHC class II antigens  (3, 4).  Moreover, 
IFN-3' can modulate the proliferation and function ofT lym- 
phocytes (5, 6) and enhance the cytolytic activity of NK cells 
(7, 8) 
The expression of IFN-'y is generally considered to be re- 
stricted to T  cells and LGL (9). There are a limited number 
of reports  on the expression of IFN-y in  other cell types 
(10-13), but the consistency and biological relevance of these 
observations are still unclear (9). The production of IFN-'y 
is generally considered to be strictly controlled, and significant 
amounts  of this  cytokine are produced  only after  specific 
stimulation (9) or in the course of certain pathologic condi- 
tions  (12). 
We have previously demonstrated that murine peritoneal 
macrophages  (PM)  constitutively  transcribe  low  levels  of 
IFN-~ mR.NA and secrete active IFN-/3, which is respon- 
sible for their antiviral  state (14,  15).  In these cells,  IFN-/3 
mRNA is rapidly degraded, but its accumulation is markedly 
increased by treatment  with LPS and IFN-3'.  This type of 
response appears to be characteristic  of macrophages,  since 
it  does not occur in other cell types (15). 
In this study, we report that IFN-'y mRNA is constitu- 
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tively expressed in PM and its accumulation is markedly in- 
creased after treatment with cycloheximide (CHX). Moreover, 
treatment of PM with IFN-'y results in overexpression of its 
gene and in IFN-'y secretion.  In contrast,  IFN-3' does not 
upregulate its own expression in mouse lymphocytes and in 
other cell types. These results suggest that PM exhibit specific 
autocrine mechanisms for the regulation of the IFN-3' gene. 
These mechanisms may play important biological roles in vivo, 
in the regulation of cell differentiation and immune response. 
Materials and Methods 
M/c~  Male C3H/HeN and Swiss nu/nu mice (5-8-wk-old) were 
obtained from Charles River, Italia S.p.A. (Milan, Italy). Mice were 
kept under  either pathogen-free  (C3H/HeN mice) or germ-free 
(nude mice) conditions  and used within 1 wk. 
Peritoneal Macrophages and Lymphocyte Cultures.  PM were har- 
vested by washing the peritoneal cavity with ILPMI 1640 medium 
containing 10% FCS and seeded in plastic dishes. After I h, nonad- 
herent cells were removed by three washes with medium. Experi- 
ments were undertaken when the cells were firmly adherent to the 
culture wells after vigorous washing. More than 95% of the cells 
stained for nonspecific esterase and were positive in immunofluores- 
cence studies with a rat mAb (F4/80) specific for mouse macro- 
phages, as previously described (16). Freshly isolated lymphocytes 
were obtained by sieving mesenteric lymph nodes into ILPMI 1640 
medium supplemented with 10% FCS and seeded at a density of 
4  x  106 cells/ml. 
Reagents.  Murine recombinant IFN-'y was a gift of Dr. G. Adolf 
(Boehringer, Vienna, Austria). RPMI 1640 medium (M. A. BiD- 
products, Walkersville, MD) was supplemented with penicillin (100 
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heat-inactivated FCS. All tissue culture reagents were purchased 
as endotoxin-free lots, as assessed  by the Limulus amebocyte assay. 
LPS from Escherichia  coli (serotype 026:B6) and CHX was purchased 
from Sigma Chemical Co.  (St. Louis, MO). PHA was obtained 
from Murex  Diagnostics  Ltd.  (Dartford,  England).  Anti-asialo 
GM1  rabbit  antibody  (17) was  purchased  from  Wako  (Neuss, 
FKG). Spleen cells taken from Swiss nu/nu mice 24 h after injec- 
tion of 50 #g of antibody to asialo GM1 showed no significant NK 
cell cytotoxicity for mouse YAC cells in vitro. 
RNA-PCR of lFN-  7  mRNA.  Total cellular RNA, prepared 
by the method of Chirgwin et al. (18), was reverse transcribed in 
a 20-/zl reaction containing 0.5 #g of total KNA, 1 #g oligo-dt 
(12-18 met; Pharmacia, Piscataway, NJ),  20 U/#I Moloney mu- 
fine leukemia virus reverse transcriptase (GIBCO BILL, Gaithers- 
burg, MD), 0.5 mM each of dATP, dCTP, dGTP, and dTTP, 10 
mM DTT, 50 mM Tris-HC1 (pH 8.3),  75 mM KC1, and 3 mM 
MgC12. After  incubation  at 37~  for 1 h,  3/~1 of the cDNA 
product was amplified in a 20-#1 reaction containing  10 mM Tris 
HC1 (pH 8.3),  50 mM KC1, 1.5 mM MgCI2, 0.001%  (wt/vol) 
gelatin, 0.2 mM each of dATP, dCTP, dGTP, and dTTP, 5 ng//~l 
each of the gene-specific upstream and downstream primers, and 
0.025 U/#I of Taq polymerase by using  a DNA thermal  cycler 
(Perkin Elmer Cetus  Corp.,  Norwalk, CT). 
The cycler program consisted of an initial denaturation of  3 min 
at 95~  followed by 30 repeated cycles of denaturation  for 40 s 
at 90~  primer annealing for 40 s at 62~  and extension for 60 s 
at 72~  A negative control lacking template RNA or RT was 
included in each experiment.  The PCR products were run on an 
2.5% agarose gel, transferred to a nylon membrane, and hybrid- 
ized with a 3Zp-labeled  IFN-y, or glyceraldehyde-3-phosphate de- 
hydrogenase (GAPDH) DNA probes. 
The sequences  for the primers used are as follows: GAPDH sense 
primer CCATGGAGAAGC~'IGGGG, antisense primer CAAAGT- 
TGTCATGGATGACC,  and probe CTAAGCAGTIGGTGGTGCA; 
IFN-  3' sense primer AACGCTACACACTGCATCTTGG,  antisense 
primer GACTTCAAAGAGTCTGAGG,  and probe GGAGGAACT- 
GGCAAAAGGA. The IFN-3, probe recognizes a 19-bp sequence 
internal to the 237 bp IFN-3' amplification  product. These sequence 
data are available from GenBank under accession number M28621. 
In Situ Hybridization.  Firmly adherent PM were washed with 
cold PBS and detached by using a rubber scraper. 5  x  104 cells 
were plated onto acetylated  glass microscope slides  by cytocentrifuge 
and processed for in situ hybridization as previously described (19). 
Samples were hybridized for 16 h at 50~  with 80 pg/#l of an 
antisense IFN-'y R,  NA probe synthetized in vitro using T7 RNA 
polymerase (Promega Corp.,  Madison,  WI), 2 #g of linearized 
IFN-3/ plasmid  DNA,  and  1  mCi  of lyophilized  ot-[3sS]UTP 
(1,000 Ci/mmol, Amersham Corp., Arlington Heights, IL) as de- 
scribed elsewhere (20). The IFN-'y probe was derived from a 330- 
bp HindlII-ClaI fragment  of the first exon of the mouse IFN-'y 
gene (19). Slides were examined in a Dialux 20 microscope as pre- 
viously described (19). 
IFN-'y Assay.  The IFN-'y released in the culture medium was 
quantitated by ELISA (INTERTEST-gamma |  Genzyme Corp., 
Cambridge,  MA). 
Results 
Expression of  lFN-  7  mRNA in PM. Upregulation by IFN-y. 
We have recently demonstrated that treatment of PM with 
CHX increases  the expression of IFN-3 mRNA as a conse- 
quence of mRNA stabilization (21).  In the course of these 
Figure  1.  RNA-PCR analysis  of 
IFN-  3" gene expression in PM treated 
with CHX or IFN-% 3  x  106 perito- 
neal cells were seeded as described in 
Materials and Methods. Adherent cells 
were treated  with IFN-3, (100  IU/ml) or 
CHX (50 #g/ml) and total  RNA was ex- 
tracted after 3 h of incubation  at 37~ 
0.5 #g of total KNA was used for the 
KNA-PCK  as described  in Materials  and 
Methods. 
experiments, we noticed that low levels of IFN-3' gene tran- 
scription could be detected in unstimulated PM after a longer 
exposure of the autoradiographs. As shown in Fig.  1, a 3-h 
treatment of these cells with CHX resulted in marked ac- 
cumulation of IFN-y mRNA. These data indicated that the 
IFN-3' gene was constitutively expressed in resting PM, but 
that its mRNA was rapidly degraded under normal conditions. 
The addition of IFN-3, to PM resulted in a significant ac- 
cumulation of its mKNA (Fig.  1). As little as 10 IU/ml of 
IFN-3, was sufficient to induce a clearly detectable accumula- 
tion of IFN-3' mRNA (data not shown). Similar results were 
also  observed  after  IFN-y  treatment  of PM  from  LPS- 
hyporesponsive C3H/HeJ mice (data not shown). 
In situ hybridization experiments were then carried out 
to detect the expression of IFN-3, mKNA in individual cells 
from IFN-y-treated PM.  Fig.  2 illustrates the results of a 
representative experiment with PM from C3H/HeN mice. 
IFN-3' mRNA-producing cells were found in IFN-q'-treated 
PM, whereas no positive cells could be detected in unstimu- 
lated PM  (Fig.  2).  The specificity of the labeled cells  was 
checked in concomitant experiments in which the in situ hy- 
bridization was performed in the presence of a 200-fold excess 
of the unlabeled IFN-3, probe. Under these conditions, no 
IFN-3, mRNA positive cells were detected in IFN-q,-treated 
PM  (data not  shown). 
Secretion of  lFN-7 by IFN-7-treated PM.  To assess whether 
the IFN-3' mKNA that accumulated in IFN-q,-treated PM 
was  translated and the corresponding protein secreted, we 
measured the kinetics of the IFN-3, release  in  the culture 
medium. In a typical experiment, PM were treated with IFN-'y 
for 3  h,  extensively washed,  and  then incubated  in  fresh 
medium (Table  1, Exp.  1).  Culture supernatants were har- 
vested at 6, 24, and 48 h and IFN-y was measured by ELISA. 
No IFN-3' was found at 6 h, whereas considerable amounts 
were detected at 24 and 48 h. 10 IU/ml of IFN-y was sufficient 
to induce some IFN-3' secretion, even though maximal produc- 
tion was obtained with 100 IU/ml of IFN-3, (Table 1, Exp. 
2). The addition of 1 IU/ml of IFN-3' to PM did not result 
in  IFN-3, secretion. 
It is noteworthy that when PM were treated with 10 IU/ml 
of IFN-3, and 3 h later with LPS (0.1-10 #g/ml), there was 
a synergistic increase in the production of IFN-3, in the cul- 
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Exp. 
Secreted IFN-3' (pg/ml)  at 
Treatment  6  h  24  h  48  h 
None  <128  <128 
IFN-'y  <128  1,125 
None  <128 
IFN-'~ (1  IU/ml)  <128 
IFN-y (10  IU/ml)  147 
IFN-'7 (100  IU/ml)  4,085 
<128 
400 
106 peritoneal cells were seeded in 24-well cluster plates, as described in 
Materials and Methods.  Adherent  PM were  treated with IFN-"/ (100 
IU/ml) for 3 h at 37~  and then extensively  washed to remove any residual 
IFN-% An aliquot of the culture medium was collected at the end of 
the wash and checked by ELISA for the presence of any residual IFN-% 
After 6, 24, and 48 h, cell supernatants were collected and the IFN-y 
measured by ELISA (Exp. 1). Some cultures (Exp. 2) received different 
concentrations of IFN-"/. Cell supematants were collected after 24 h for 
IFN-3' titration.  Values represent the mean of duplicate samples. Stan- 
dard deviation did not exceed 15%. 
Figure  2.  Detection by in situ hybridization of IFN-3/mRNA in in- 
dividual IFN-3'-treated PM. PM from C3H/HeN mice were prepared as 
described in Materials and Methods. Firmly adherent PM were incubated 
with or without IFN-"/(100  IU/ml) for 3 h at 37~  Cells were then 
processed for in situ hybridization as described in Materials and Methods. 
(.4) Untreated  PM.  (B)  IFN-~/-treated PM.  An  example of a IFN-~/ 
mRNA-expressing  cell is shown,  x800. 
ture medium  (Fig.  3),  as compared with  single treatments. 
Under these conditions, no IFN-3' was secreted by PM treated 
with LPS alone (Fig. 3). Further experiments were performed 
to determine the minimal LPS concentration required for in- 
ducing an increased secretion of IFN-3, in PM pretreated with 
10 IU/ml of IFN-',/. As low as I  ng/ml of LPS was sufficient 
to induce a twofold increase in IFN-3, secretion as compared 
with  PM  treated  with  IFN-3,  alone  (data  not  shown). 
We then  performed experiments  to evaluate the residual 
IFN-3' in supernatant  of PM shortly after IFN-'y treatment. 
PM cultures  were treated with  100 IU/ml of IFN-'y (mean 
value by ELISA,  12,720  pg/ml).  After a  15-rain incubation 
at  37~  equal  amounts  of IFN-"/(mean  value by ELISA, 
12,716 pg/ml) were still found in the culture medium,  sug- 
gesting that very few IFN-3~ molecules were bound  and/or 
internalized in PM. Cells were then extensively washed three 
times with fresh medium and cultured for 24 h  at 37~  No 
IFN-3' was  detected  in  the  culture  fluids  15  rain  after cell 
washings.  However, a clear-cut production of IFN-3~ (mean 
value by ELISA,  1,522  pg/ml)  was  found 24 h  later in  the 
supernatants,  suggesting that newly synthesized IFN-3~ was 
secreted  after  IFN-3,  stimulation. 
Specificity of  the IFN-7-induced  Upregulation of  lFN-'y Gene 
Expression in PM.  Figs. 4 and 5 illustrate the results of two 
sets of experiments aimed at investigating the cell specificity 
of the IFN-qr-induced upregulation of IFN-3, expression.  In 
a  first set of experiments,  we compared macrophages with 
different  cell types for the response to IFN-%  In lympho- 
cytes freshly harvested from mesenteric lymph nodes, the ad- 
dition of IFN-3/did not result in IFN-3~ mRNA  accumula- 
tion,  whereas  upregulation of IFN-3' gene  expression  was 
observed in  PHA-treated  cultures  (Fig.  4).  IFN-y did not 
800  - 
.  /e~e~e  +  IFN-y  / 
600  - 
~ 400- 
200  - 
< 128  ;~..---,~l  o  o  -  IFN-Y 
o  0.1  1  10 
L PS (pg/ml) 
Figure  3.  LPS  potentiates 
IFN-3r  production  in  IFN-~/- 
treated PM.  106 peritoneal cells 
were  seeded in  24-well cluster 
plates as described in the legend 
to Table 1.  Adherent cells were 
treated with IFN~ (10 IU/ml) for 
3 h at 37~  Cells were washed 
three  times  and  subsequently 
treated with different concentra- 
tions of LPS. Cell  supernatants 
were collected  for IFN-3' titration 
after  24  h  at  37~  Values re- 
present  the  mean  of  duplicate 
samples. Standard deviations did 
not exceed 15%. 
1733  Di Marzio et al.  Brief Definitive Report Figure  4.  Effect  of  IFN-3,  or PHA on the expression  of IFN-3,  mRNA 
in primary lymphocytes.  Primary  lymphocytes,  seeded as described in 
Materials and Methods, were treated with IFN-3, (100 IU/ml) or PHA 
(2.5/~g/ml). Total RNA was extracted  after 6 and 18 h of treatment at 
37~  and analyzed  by IkNA-PCR. 
induce accumulation of its own mRNA in mouse cell lines 
such as ANA-1,  Eb  lymphoma cells,  and Friend erythro- 
leukemia cells or human peripheral blood monocytes (data 
not  shown).  In  a  second  set  of experiments,  we  further 
confirmed that IFN-3,-induced upregulation of  IFN-'y mRNA 
expression  was a specific response  of macrophages by using 
PM  from  either  untreated  or  anti-asialo  GMl-treated  T 
cell-deficient nude mice. As shown in Fig.  5, IFN-y treat- 
ment of PM harvested from nude mice resulted in a marked 
accumulation of IFN-3' mRNA as well as in IFN secretion. 
Similar results were obtained in PM harvested from anti-asialo 
GMl-treated nude mice (Fig.  5). 
Discussion 
The two major findings reported in this article can be sum- 
marized as follows: (a) IFN-y mRNA is constitutively ex- 
pressed at very low levels in unstimulated PM and accumu- 
lates after treatment with CHX; and (b) IFN-3' upregulates 
the expression of its own gene and induces IFN-3, secretion 
in PM, but not in other cell types (i.e., lymphocytes and sev- 
eral mouse cell lines). 
It is generally assumed that T  cells and LGL are the only 
two cell types capable of producing IFN-3' (9). To our knowl- 
edge, IFN-3, production by mouse cells other than T  cells 
and LGL has been reported in only two studies: by perito- 
neal cells cocultivated with syngeneic tumor cells (22) and 
by lymphokine-activated  spleen macrophages (23). The finding 
that IFN-y mRNA is expressed  in resting PM and is up- 
regulated by IFN-3, itself indicates that macrophages should 
be regarded as potentially important producers of IFN-y in 
vivo. Cockfield et al. (24) recently reported that IFN-3, up- 
regulates the expression of its own mRNA in normal and 
LPS-treated mice. Since this also occurs in T  cell-deficient 
nude mice, these authors conclude that "the cell population 
responsible for IFN-gamma secretion is probably the LGL 
or NK cell fraction, the only non-T cells able to express IFN- 
gamma after stimulation in vitro or in vivo" (24).  In light 
of our data on the upregulation of IFN-3' expression by IFN-'y 
itself in PM, we can assume that Cockfield et al.  (24) may 
have neglected a possible role of macrophages in the IFN- 
Figure  5.  IFN-~'-induced  upregulation  of IFN-3, gene expression in 
PM from untreated  or anti-asialo  GMl-treated  nude mice. (A) 3 x  106 
peritoneal cells harvested  from either untreated or anti-asialo  GM1 inoc- 
ulated  nude  mice  were  seeded  as described  in Materials  and Methods.  RNA 
extraction and RNA-PCR  were performed  as described  in the legend  to 
Fig. 1. (B) 106 peritoneal cells harvested from either untreated or anti- 
asialo GMl-treated  nude mice were seeded  as described  in the legend to 
Table 1. Adherent PM were treated with IFN-3, (100 IU/ml) for 3 h at 
37~  and then extensively  washed. Cell supernatants  were collected  for 
IFN-'y titration after 24 h. 
y-mediated amplification of the IFN-'y production observed 
in their in vivo studies.  In this study, we observed  a repro- 
ducible upregulation of IFN-3' mRNA by IFN-3, (by RNA- 
PCR and in situ hybridization) only using firmly adherent 
macrophages. The specificity of this autostimulatory loop of 
IFN-3' production is indicated by the fact that lymphocytes 
from mesenteric lymph nodes, as well as different mouse cell 
lines and human monocytes, did not show any evidence of 
IFN-3, mRNA accumulation after treatment with IFN-3'. 
It is noteworthy that this response was also found in PM 
from either untreated or anti-asialo GMl-treated T cell-de- 
ficient nude mice,  further indicating that the upregulation 
1734  Regulation  of IFN-3, Expression in Mouse Peritoneal Macrophages of IFN-3, expression was not due to any possible contamina- 
tion of PM with residual T  or NK cell populations. 
In the last few years several reports have indicated that one 
cytokine may regulate the expression of other cytokines or 
of their receptors  in an autocrine or paracrine manner (1). 
Additional complexity of the cytokine network is suggested 
by the observation that certain cytokine genes may be regu- 
lated in vitro and in vivo by their own products (24-27). 
Concerning IFN-'y expression, Hardy and Sawada (28) re- 
ported that IFN-3' can upregulate its own gene expression 
in lectin-activated human PBMC. The data reported here rep- 
resent the first example that the simple addition of IFN-3' 
alone can upregulate its own gene expression in vitro. This 
type of response appears to be a unique property of macro- 
phages. 
Recent studies in mice with disrupted IFN-3, genes (29) 
as well as in mice lacking the IFN-y receptor (30) have un- 
derlined the relevance of the IFN-y system in mice. IFN-'y 
plays a crucial role in a number of immune responses  and 
is the major cytokine involved in the regulation of macro- 
phage activation and differentiation (9). We suggest that au- 
tocrine mechanisms of regulation of IFN-'y expression may 
play important biological roles in vivo for maintaining cer- 
tain macrophage functions. The ability of macrophages to 
produce suitable amounts of IFN-3' after stimulation with 
IFN-y itself suggests a specific role of macrophage IFN-3, 
in the regulation of cell differentiation and immune response. 
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